Pandemic

Massive analysis of medical records from coronavirus patients reveals treatment regimens for current, and potential future, viral pandemics

Feedback from UTSW clinical research professionals indicates positive impact of adjustments on patient and staff experience

This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

Addresses major testing need in developing world; also in US, where reagent supplies are again dwindling

Longitudinal study of COVID-19 convalescent plasma donors sheds light on ideal timing to donate

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

Global network to focus on spillover potential

Study in 38 Michigan hospitals shows need for faster in-hospital testing for coronavirus and other infections, which could reduce overuse of antibiotics